Tetrylammonium

Tetrylammonium

SCHEMBL17865405

BOCCCCC.CC[N+](CC)(CC)CC

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 4/20 0.44
TSHR P16473 3/20 0.40
NFKB1 P19838 1/20 0.40
KCNA1 Q09470 1/20 0.40
SLC22A1 O15245 3/20 0.39
SLC22A2 O15244 1/20 0.39
KDM4E B2RXH2 1/20 0.38
PMP22 Q01453 1/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
HIF1A Q16665 1/20 0.36
HSD17B10 Q99714 1/20 0.36
THRB P10828 2/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4556157 0.87
Tetrapropylammonium SCHEMBL17865413 0.85 SLC22A1 (0.50) DNM1TSHRSLC22A1SLC22A2ALDH1A1
Tetrabuthylammonium SCHEMBL17865411 0.85 SLC22A1 (0.60) DNM1TSHRSLC22A1SLC22A2ALDH1A1
Tetramethylammonium Ion SCHEMBL17865408 0.84 DNM1 (0.38) DNM1TSHRSLC22A1SLC22A2THRB
SCHEMBL17009071 0.84 THRB (0.50) TSHRTHRBMEN1HTTKMT2A
SCHEMBL13551004 0.84 THRB (0.50) TSHRTHRBMEN1HTTKMT2A
SCHEMBL7164575 0.84
SCHEMBL12760684 0.84 THRB (0.50) TSHRTHRBMEN1HTTKMT2A
SCHEMBL10940757 0.84
SCHEMBL28160682 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3037398-B1 METHOD FOR MANUFACTURING CHEMICAL COMPOUND SUMITOMO CHEMICAL CO (JP) 2021-03-10 EP disclosed
US-9982087-B2 Method for producing compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-05-29 US disclosed
US-20160200861-A1 METHOD FOR PRODUCING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-07-14 US disclosed
EP-3037398-A1 METHOD FOR MANUFACTURING CHEMICAL COMPOUND Sumitomo Chemical Company, Limited (JP) 2016-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160200861-A1 METHOD FOR PRODUCING COMPOUND NUDT1, OSGEP, CNOT9 DNM1 1005/4885TSHR 3996/4885NFKB1 1472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.